… Here, we describe long-term side effects in three patients receiving erlotinib for adenocarcinoma
in the lung. All three had an activating mutation of the EGFR gene. In view of good …

… side effects and their management in patients with cancer treated with cetuximab or erlotinib…
(our 17 patients of 28 treated with erlotinib by the oncologists). This percentage is similar to …

… The toxicity profile of erlotinib includes diarrhoea and rash, with no haematological side
effects. Predictive factors for response … This article reviews the current clinical status of erlotinib. …

… side-effects, severity, time of appearance and therapeutic responses. One patient referred
hypertricosis 18 days after starting erlotinib, … alterations with this drug occur as a late sideeffect. …

… , side effects, and dose adjustment. Discontinuation and reasons for discontinuation will
be asked in a short questionnaire when a patient stops the erlotinib treatment prematurely. …

… Erlotinib is an inhibitor of human epidermal growth factor approved for treating nonsmall
cell … cutaneous reactions caused by erlotinib and assess the management of such effects. …

… of erlotinib-related skin toxicities thereby enabling patients to continue erlotinib treatment. In
… the treatment of erlotinib-related cutaneous side effects in Japanese patients with advanced …

… Each of these side effects was mild (grade 1 – 2) and resolved following continuation of
erlotinib. No partial or complete remissions were observed in the 40patients treated on this …

… has a favorable safety profile, with rash and diarrhea being the most common side effects.
Toxicities classically reported with chemotherapy were not noted in this trial. No drug-related …

… Skin rash was the most common side effect (80.6%). Two … NSCLC patients. In addition,
several clinical studies indicated that erlotinib could confer benefits in certain patients with …